Three Polish research teams among the winners of the international call JPco-fuND 2

We are pleased to announce that three projects involving Polish researchers have been awarded funding in the JPco-fuND 2 call for multinational research projects on personalised medicine for neurodegenerative diseases. Within the JPco-fuND 2 over EUR 29,3 million have been granted to 18 research projects.

Complete list of the projects recommended for funding

JPco-fuND 2 has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 825664.

Polish projects awarded within the call:

1. NMJ-on-a-Chip: Humanized high-throughput co-culture system for motor neuron diseases. Polish Principal Investigator: prof. dr hab. Józef Dulak, Jagiellonian University in Cracow. The project will involve research teams from France, Germany, Israel, Italy, Netherlands
2. OligoFIT: Oligomer-Focused Screening and Individualized Therapeutics to target Neurodegenerative Disorders. Polish Principal Investigator: dr Piotr Hańczyc, University of Warsaw. The project will involve research teams from Denmark, Germany, Latvia, Portugal, United Kingdom
3. Gums&Brains: Alzheimer’s disease as a co-morbidity of chronic periodontitis with Porphyromonas gingivalis as a causative link between both diseases. Polish Principal Investigator: prof. dr hab. Jan Stanisław Potempa (Project Leader), Jagiellonian University in Cracow. The project will involve research teams from Czech Republic, Denmark, Germany, Norway

Congratulations to all the laureates.